Finally, we found that decreased GCN5L1 levels, rather than alterations in GLS1 or GLS2 expression, are associated with human HCC tumours and support that changes in glutaminase activity are important in the pathogenesis of this disease. The gene discussed is GLS; the disease is hepatocellular carcinoma.